Cargando…
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells
Mitotane is the only drug approved for the treatment of adrenocortical carcinoma (ACC). The regimen to be added to mitotane is a chemotherapy including etoposide, doxorubicin, and cisplatin. This pharmacological approach, however, has a limited efficacy and significant toxicity. Evidence indicates t...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226156/ https://www.ncbi.nlm.nih.gov/pubmed/32283844 http://dx.doi.org/10.3390/cancers12040928 |
_version_ | 1783534224543842304 |
---|---|
author | Abate, Andrea Rossini, Elisa Bonini, Sara Anna Fragni, Martina Cosentini, Deborah Tiberio, Guido Albero Massimo Benetti, Diego Hantel, Constanze Laganà, Marta Grisanti, Salvatore Terzolo, Massimo Memo, Maurizio Berruti, Alfredo Sigala, Sandra |
author_facet | Abate, Andrea Rossini, Elisa Bonini, Sara Anna Fragni, Martina Cosentini, Deborah Tiberio, Guido Albero Massimo Benetti, Diego Hantel, Constanze Laganà, Marta Grisanti, Salvatore Terzolo, Massimo Memo, Maurizio Berruti, Alfredo Sigala, Sandra |
author_sort | Abate, Andrea |
collection | PubMed |
description | Mitotane is the only drug approved for the treatment of adrenocortical carcinoma (ACC). The regimen to be added to mitotane is a chemotherapy including etoposide, doxorubicin, and cisplatin. This pharmacological approach, however, has a limited efficacy and significant toxicity. Evidence indicates that ACC seems to be sensitive to alkylating agents. Trabectedin is an anti-tumor drug that acts as an alkylating agent with a complex mechanism of action. Here, we investigated whether trabectedin could exert a cytotoxic activity in in vitro cell models of ACC. Cell viability was evaluated by MTT assay on ACC cell lines and primary cell cultures. The gene expression was evaluated by q-RT-PCR, while protein expression and localization were studied by Western blot and immunocytochemistry. Combination experiments were performed to evaluate their interaction on ACC cell line viability. Trabectedin demonstrated high cytotoxicity at sub-nanomolar concentrations in ACC cell lines and patient-derived primary cell cultures. The drug was able to reduce /β catenin nuclear localization, although it is unclear whether this effect is involved in the observed cytotoxicity. Trabectedin/mitotane combination exerted a synergic cytotoxic effect in NCI-H295R cells. Trabectedin has antineoplastic activity in ACC cells. The synergistic cytotoxic activity of trabectedin with mitotane provides the rationale for testing this combination in a clinical study. |
format | Online Article Text |
id | pubmed-7226156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72261562020-05-18 Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells Abate, Andrea Rossini, Elisa Bonini, Sara Anna Fragni, Martina Cosentini, Deborah Tiberio, Guido Albero Massimo Benetti, Diego Hantel, Constanze Laganà, Marta Grisanti, Salvatore Terzolo, Massimo Memo, Maurizio Berruti, Alfredo Sigala, Sandra Cancers (Basel) Article Mitotane is the only drug approved for the treatment of adrenocortical carcinoma (ACC). The regimen to be added to mitotane is a chemotherapy including etoposide, doxorubicin, and cisplatin. This pharmacological approach, however, has a limited efficacy and significant toxicity. Evidence indicates that ACC seems to be sensitive to alkylating agents. Trabectedin is an anti-tumor drug that acts as an alkylating agent with a complex mechanism of action. Here, we investigated whether trabectedin could exert a cytotoxic activity in in vitro cell models of ACC. Cell viability was evaluated by MTT assay on ACC cell lines and primary cell cultures. The gene expression was evaluated by q-RT-PCR, while protein expression and localization were studied by Western blot and immunocytochemistry. Combination experiments were performed to evaluate their interaction on ACC cell line viability. Trabectedin demonstrated high cytotoxicity at sub-nanomolar concentrations in ACC cell lines and patient-derived primary cell cultures. The drug was able to reduce /β catenin nuclear localization, although it is unclear whether this effect is involved in the observed cytotoxicity. Trabectedin/mitotane combination exerted a synergic cytotoxic effect in NCI-H295R cells. Trabectedin has antineoplastic activity in ACC cells. The synergistic cytotoxic activity of trabectedin with mitotane provides the rationale for testing this combination in a clinical study. MDPI 2020-04-09 /pmc/articles/PMC7226156/ /pubmed/32283844 http://dx.doi.org/10.3390/cancers12040928 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Abate, Andrea Rossini, Elisa Bonini, Sara Anna Fragni, Martina Cosentini, Deborah Tiberio, Guido Albero Massimo Benetti, Diego Hantel, Constanze Laganà, Marta Grisanti, Salvatore Terzolo, Massimo Memo, Maurizio Berruti, Alfredo Sigala, Sandra Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells |
title | Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells |
title_full | Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells |
title_fullStr | Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells |
title_full_unstemmed | Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells |
title_short | Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells |
title_sort | cytotoxic effect of trabectedin in human adrenocortical carcinoma cell lines and primary cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226156/ https://www.ncbi.nlm.nih.gov/pubmed/32283844 http://dx.doi.org/10.3390/cancers12040928 |
work_keys_str_mv | AT abateandrea cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT rossinielisa cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT boninisaraanna cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT fragnimartina cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT cosentinideborah cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT tiberioguidoalberomassimo cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT benettidiego cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT hantelconstanze cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT laganamarta cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT grisantisalvatore cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT terzolomassimo cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT memomaurizio cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT berrutialfredo cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells AT sigalasandra cytotoxiceffectoftrabectedininhumanadrenocorticalcarcinomacelllinesandprimarycells |